Table 3.
Clinical series of lymphoepithelial carcinoma of the oral cavity, oropharynx, and sinonasal region
| Report | Cases | Mean age | Sex | Site | EBV | Treatment | Survival |
|---|---|---|---|---|---|---|---|
| Singhi [30] | 22 | n/a | n/a | Oropharynx: 19, other sites: 3 | None | n/a | From 2 to 180 (median 23 months), 21 disease free, one refused treatment and died |
| Jeng [31] | 13 | 58 | Male: 9, female: 4 | Sinonasal regio | All pos. | S/R/SR/RS/SRC/No | 61% disease free |
| Zong [10] | 20 | 46.3 | Male: 15, female: 5 | Nasal cavity: 17, maxillary sinus: 3 | All pos. | n/a | n/a |
| Dubey [32] | 34 | n/a | n/a | Maxillary sinus: 1 nasal cavity: 1, other sites 32 | n/a | R | 100% of two sinonasal cases |
| Klijanienko [33] | 18 | 55.5 | Male: 13, female: 5 | Tonsils: 18 | Pos. 4/Tested 7 | R | 10 year 77% alive |
| Möller [34] | 3 | n/a | n/a | Tonsillas or pharyngopalatine arch | n/a | n/a | n/a |
EBV Epstein-barr virus, n/a not applicable, pos positive, S surgery, R radiotherapy, C chemotherapy